Status:

COMPLETED

AScVS and/ or Prazosin for Scorpion Envenomation

Lead Sponsor:

Haffkine Bio-Pharmaceutical Corporation Ltd.

Conditions:

Scorpion Envenomation

Eligibility:

All Genders

12-65 years

Phase:

PHASE3

Brief Summary

The data available for the efficacy of AScVS and prazosin is generated through different trials done in different clinical setting. Hence it was felt worthwhile to confirm the documented efficacy of A...

Detailed Description

Red Scorpion (Mesobuthus Tamulus Concanesis Pocock) sting is a common medical emergency in the coastal regions of India and is a cause for considerable morbidity and mortality. Signs and symptoms sho...

Eligibility Criteria

Inclusion

  • (All of the following)
  • Patients of both sexes, in the age range of 12-65 years
  • reporting to the PHC/ hospital within 48 hours of scorpion sting and
  • associated with s/s of scorpion envenomation having composite score between 5 and 21 (as computed based on the criteria below:)
  • Criteria Grade Symptoms
  • Sweating 0 Limited to the extremity of the sting site.
  • Minimal sweating all over the body, slight nasal secretions
  • Generalized sweating with rigors and cold extremities.
  • Gen.profuse sweating,wetting of clothes and cold clammy skin.
  • Pulse rate 0 70- 90
  • 91 - 100
  • 101 - 120 or \< 70
  • 121 - 140 or \< 60 or irreg pulse
  • 141 - 160
  • \> 160
  • Respiratory rate 0 \< 20
  • 20 - 30
  • 31 - 40 without crepitations
  • 31 - 40 with crepitations
  • \> 40 with crepitations
  • \> 40 with crepitations and cyanosis
  • Blood pressure 0 120/80
  • Systolic: 121 -140 and diastolic: 81 -90
  • Systolic: 141 -160 and diastolic: 91-100
  • Syst: 161 -180 and diast: 101-110 Or syst \<100
  • Syst: 181 -200 and diast: 111-120 Or syst \<100
  • Syst: \> 200 and diast: \>120 Or syst \< 60
  • CNS effects 0 No sensory involvement
  • Minimal tingling numbness around mouth
  • Tingling, numbness around mouth and giddiness
  • Altered sensorium, patient roudy
  • Patient semiconscious
  • Patient unconscious
  • Priapism 2 Slight erection 3 Strong erection
  • To obtain a composite score, grades for individual criterion will be added. Maximum score: 25 and minimum score: 0

Exclusion

  • (Any of the following)
  • Composite score less than 5 and greater than 21.
  • Grade of 5 in any of the criterion
  • Severe Pulmonary edema with oxygen saturation below 80%.
  • Severe scorpion envenomation with reporting time more than 2 days
  • Any other serious medical disease which/treatment of which may confound the results e.g. cardiac diseases, diabetes, renal diseases etc.
  • Severe anaphylactic reaction to any of the study drugs
  • Patient (or relative in case of child) not willing to participate

Key Trial Info

Start Date :

September 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2007

Estimated Enrollment :

81 Patients enrolled

Trial Details

Trial ID

NCT00753064

Start Date

September 1 2006

End Date

December 1 2007

Last Update

September 16 2008

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Kushte Hospital

Chiplūn, Maharashtra, India, 415605

2

Natu Hospital

Chiplūn, Maharashtra, India, 415605

3

Sane Hospital

Chiplūn, Maharashtra, India, 415605

4

Mangaon cottage hospital, Mangaon.

Dist. Raigad., Maharashtra, India, 402104